William Mc Comb, MD
Internal Medicine · Amory, MSNPI 1043235047
Payments from drug & device makers
Across 174 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$544
- Kerecis Limited$461
- AbbVie$448
- Urgo Medical North America, LLC$311
- Mimedx Group, Inc.$238
- Paratek Pharmaceuticals, Inc.$223
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,567100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 29 | $544 |
| Kerecis Limited | 7 | $461 |
| AbbVie(2 entities) | 32 | $448 |
| Urgo Medical North America, LLC | 13 | $311 |
| Mimedx Group, Inc. | 10 | $238 |
| Paratek Pharmaceuticals, Inc. | 10 | $223 |
| Convatec Inc. | 9 | $212 |
| Organogenesis Inc. | 7 | $121 |
| Nestle Healthcare Nutrition Inc. | 7 | $117 |
| Integra Lifesciences Corporation | 2 | $109 |
| Reapplix Inc. | 5 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $101 |
| Johnson & Johnson(2 entities) | 5 | $80 |
| Sanofi-aventis U.S. LLC | 5 | $73 |
| Solventum Corporation | 3 | $54 |
| Reprise Biomedical, Inc. | 2 | $51 |
| Daiichi Sankyo Inc. | 3 | $49 |
| Ironwood Pharmaceuticals, Inc | 2 | $32 |
| Novo Nordisk | 2 | $31 |
| Melinta Therapeutics, LLC | 2 | $29 |
| KCI USA, Inc. | 2 | $28 |
| Amgen | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $18 |
| Hartmann USA, Inc. | 1 | $16 |
| La Jolla Pharmaceutical Company | 1 | $15 |
| Aroa Biosurgery Incorporated | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Intercept Pharmaceuticals, Inc. | 1 | $12 |
| Bsn Medical Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,567 in reported general payments places this provider in the 80th percentile of 846 internal medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 26 | $634 |
| Doxycycline Monohydrate | 50 | $578 |
| Levofloxacin | 61 | $387 |
| Pantoprazole Sodium | 44 | $369 |
| Lamotrigine | 11 | $341 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 37 | $324 |
| Gabapentin | 33 | $318 |
| Gentamicin Sulfate | 12 | $317 |
| Amiodarone Hcl | 15 | $302 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $256 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $222 |
| Cephalexin | 33 | $202 |
| Tamsulosin Hcl | 22 | $194 |
| Levothyroxine Sodium | 51 | $190 |
| Quetiapine Fumarate | 18 | $161 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Amory
- James HallBrookhaven$4.8M
- Bob HutchinsJackson$4.6M
- Sidney GortonBelzoni$571K
- David PendleyGulfport$336K
- Sarah KerutJackson$319K
- Gabriel HernandezJackson$196K
- Kelly WilkinsonJackson$183K
- Magdy Gorgi-MikhailBiloxi$157K
- Christina BarlowJackson$129K
- Arnold JacksonHattiesburg$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.